Valeant Pharmaceuticals International (VRX.TO) is near a deal to buy Salix Pharmaceuticals Ltd (SLXP.O) for about $10 billion, the Wall Street Journal reported on Saturday.
Valeant nears deal to buy Salix for about $10 billion: WSJ
By
© Reuters All rights reserved.
Join the Conversation